newsfilter
← Latest News
Business Wire·

Vistagen to Present at the Jefferies 2025 Global Life Sciences Conference New York

Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called